France Archives

News and Trends 28 Oct 2021

DNA Manufacturing Startups Net Venture Capital Windfalls

Touchlight Genetics and DNA Script have closed major venture financing rounds in the last month as investor excitement mounts over the next generations of DNA manufacturing. DNA Script made a big splash in Paris this week as it raked in €142M in Series C funding. The company will ramp up the commercialization of its benchtop […]

October 28, 2021 - 6 minutesmins - By Jonathan Smith

News and Trends 26 Oct 2021

Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial

Last week, the French vaccine maker Valneva announced promising phase III trial results of its inactivated Covid-19 vaccine: a well-established technology that could confer broader immunity to the virus than shots currently on the market. Valneva’s vaccine candidate consists of a killed or ‘inactivated’ version of SARS-CoV-2, the virus responsible for Covid-19. The vaccine was […]

October 26, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 22 Oct 2021

Gene-Edited T Cell Therapy Players Battle Safety Doubts

Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused all clinical development following the detection of an unexpected genetic change in a clinical trial. Industry experts see these events as a reality check for the nascent field. Off-the-shelf treatments that use genetically engineered T cells to treat diseases suffered […]

October 22, 2021 - 5 minutesmins - By Anita Chakraverty

Chikungunya vaccine clinical trial Valneva

News and Trends 19 Aug 2021

Chikungunya Vaccine First to Succeed in Phase III Trial

In a significant step in the fight against tropical disease, the mosquito-borne viral disease chikungunya may become preventable with a new vaccine candidate from French biotech Valneva that just passed phase III trials. The results of the phase III trial revealed that a single dose of the live attenuated vaccine developed by Valneva induced the […]

August 19, 2021 - 3 minutesmins - By Victor Kotsev

News and Trends 28 Jul 2021

Microbiome Medicines Could Power Up CAR-T Cell Therapies

The microbiome could pave new cancer immunotherapy inroads for European biotechs, bolstered by preclinical findings that gut bacteria metabolites may help CAR-T cell therapies penetrate and kill solid tumors. A recent study conducted by researchers at Philipps-University Marburg, University Hospital Würzburg, and the Leeds-based company 4D Pharma showed that metabolites produced by the gut bacteria […]

July 28, 2021 - 5 minutesmins - By Mark Zipkin

carbios bioplastic avantium Industrial plant sustainability environment

News and Trends 18 May 2021

Avantium and Carbios Capitalize on Growing Bioplastics Demand

As the EU phases out a wide range of single-use plastics this year, investor interest is steadily increasing for adopting easily recyclable or bio-based plastics. In recent weeks, European biotechs Carbios and Avantium have taken big steps towards meeting rising demand. With millions of tons of plastic waste littering the ocean floors, truly solving our […]

May 18, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 1 Sep 2020

Microbiome Therapies Threatened by Covid-19 Restrictions

Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of stool samples. Though these measures are now loosening in France, key safety challenges remain for companies using fecal microbiota. Fecal microbiota transplants — procedures where healthy individuals donate their gut microbes to a patient — have changed how we treat […]

September 1, 2020 - 5 minutesmins - By Jonathan Smith

News and Trends 29 Jul 2020

Update: DNA Script Raises €80M to Bring Rapid DNA Synthesis to the Lab

Update on 29/07/2020: DNA Script has increased the total raised in its Series B round to €80M ($89M). The additional funds will support the commercial launch of the company’s benchtop DNA printer, which is designed to allow same-day DNA synthesis directly in the lab bench. The company is planning to launch a beta testing program […]

July 29, 2020 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Jul 2020

Biological Fungicide Clears Wheat of Rust Disease in European Field Trial

A fungicide derived from amoeba has proven effective at protecting wheat from rust disease and other major fungal diseases at bay. Developed by French company Amoéba, this product could provide an eco-friendly solution to a growing problem in agriculture worldwide. Every year, over 5 million tons of wheat are lost to rust disease globally, which […]

July 27, 2020 - 2 minutesmins - By Kostas Vavitsas

News and Trends 8 Jul 2020

Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines

Osivax, a Lyon-based biotechnology company, secured €17.5M from the European Innovation Council and €15.1M from Bpifrance. The funding will be used to develop vaccines that protect from all current – and even future – flu and coronavirus outbreaks. Most current vaccines have a specific target protein they work against. They train the immune system to […]

July 8, 2020 - 3 minutesmins - By Kostas Vavitsas

News and Trends 22 Apr 2020

€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating

The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against solid tumors into clinical trials within a year. Led by the US-Japanese venture capital firm Remiges Ventures, the Series A round also included contributions from Japanese investment firm ANRI and French private equity investor Irdi Soridec Gestion. The cash injection […]

April 22, 2020 - 3 minutesmins - By Anita Chakraverty

News and Trends 26 Mar 2020

Novacyt Launches Two-Hour Coronavirus Test After FDA Approval

The French clinical diagnostics specialist Novacyt has announced FDA authorization for its fast and easily transportable test for the coronavirus disease COVID-19. The company is also rolling out the kit this week via manufacturing and distribution partnerships across Europe. The test received an Emergency Use Authorization from the FDA, which means it can only be […]

March 26, 2020 - 3 minutesmins - By External Contributor

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France

DNA Manufacturing Startups Net Venture Capital Windfalls

Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial

Gene-Edited T Cell Therapy Players Battle Safety Doubts

Chikungunya Vaccine First to Succeed in Phase III Trial

Microbiome Medicines Could Power Up CAR-T Cell Therapies

Avantium and Carbios Capitalize on Growing Bioplastics Demand

Microbiome Therapies Threatened by Covid-19 Restrictions

Update: DNA Script Raises €80M to Bring Rapid DNA Synthesis to the Lab

Biological Fungicide Clears Wheat of Rust Disease in European Field Trial

Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines

€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating

Novacyt Launches Two-Hour Coronavirus Test After FDA Approval

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!